Carson Wealth (CWM LLC)
ABOS icon

Carson Wealth (CWM LLC)’s Acumen Pharmaceuticals ABOS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205 Sell
87
-60
-41% -$153 ﹤0.01% 5529
2025
Q4 		$0 Sell
147
-597
-80% -$1.18K ﹤0.01% 5342
2025
Q3 		$1K Sell
744
-3,392
-82% -$4.69K ﹤0.01% 5070
2025
Q2 		$5K Sell
4,136
-1
-0% -$1 ﹤0.01% 4579
2025
Q1 		$5K Buy
4,137
+3,908
+1,707% +$5.58K ﹤0.01% 4421
2024
Q4 		$0 Buy
229
+61
+36% +$147 ﹤0.01% 4872
2024
Q3 		$0 Buy
+168
New +$456 ﹤0.01% 4783

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ABOS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Acumen Pharmaceuticals (ABOS) stake by 41% in Q1 2026, selling an estimated $153 and leaving 87 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #5529.

Carson Wealth (CWM LLC) first reported a position in ABOS in Q3 2024 and has held it in 7 quarters since. The position peaked at $5K in Q2 2025. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 87 shares of Acumen Pharmaceuticals worth $205 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 60 Acumen Pharmaceuticals shares in Q1 2026, an estimated $153.
  • Acumen Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5529 holding.
  • Carson Wealth (CWM LLC) first reported a position in Acumen Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s Acumen Pharmaceuticals position peaked at $5K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.